Zydus Lifesciences Ltd | Scrip Code : 532321 | Quarter ending :June 2018 |
| Declaration
| |
|
|
Whether the Listed Entity has issued any partly paid up shares? | No | Whether the Listed Entity has issued any Convertible Securities ? | No | Whether the Listed Entity has issued any Warrants ? | No | Whether the Listed Entity has any shares against which depository receipts are issued? | No | Whether the Listed Entity has any shares in locked-in? | No | Whether any shares held by promoters are pledge or otherwise encumbered? | No | Whether company has equity shares with differential voting rights? | No |
| Summary statement holding of specified securities
| |
|
|
(A) Promoter & Promoter Group | 8 | 76,56,90,230 | 76,56,90,230 | 74.79 | 76,56,90,230 | 74.79 | 76,56,90,230 | - | - | - | (B) Public | 1,03,202 | 25,80,52,370 | 25,80,52,370 | 25.21 | 25,80,52,370 | 25.21 | 25,39,62,353 | - | - | - | (C1) Shares underlying DRs | | | | 0.00 | | 0.00 | | - | - | - | (C2) Shares held by Employee Trust | | | | 0.00 | | 0.00 | | - | - | - | (C) Non Promoter-Non Public | | | | 0.00 | | 0.00 | | - | - | - | Grand Total | 1,03,210 | 1,02,37,42,600 | 1,02,37,42,600 | 100.00 | 1,02,37,42,600 | 100.00 | 1,01,96,52,583 | - | - | - |
| Note:C=C1+C2 Grand Total=A+B+C
|